2011
DOI: 10.5858/arpa.2011-0170-ra
|View full text |Cite
|
Sign up to set email alerts
|

Managing Transfusion Service Quality

Abstract: N Context.-Providing blood products for transfusions is a complex process subject to errors both within and outside the transfusion service. Transfusion-related errors can have grave consequences for the patient undergoing transfusion. As with many processes performed within health care systems, there is an expectation of error-free practice. Although this is an unobtainable goal, a focused qualitymanagement plan, employing a medical event reporting system in a just working environment, can effect measurable s… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 12 publications
0
1
0
Order By: Relevance
“…The quality assurance must cover all aspects of transfusion, including donor selection, blood collection, processing, storage, and transfusion. [1][2][3][4] The key role of quality in the transfusion system is well reflected in the standards of the American Association of Blood Banks (AABB) 5 and the Italian Society of Transfusion Medicine and Immunohematology (SIMTI). 6 On the contrary, the adoption of a quality assurance program is mandatory and regulated by the current Good Manufacturing Practice (cGMP) of the Food and Drug Administration (FDA) in the United States 7 and, in Europe, by the Directives 2002/98/EC and 2005/62/EC of the European Parliament, which must be adopted by all member states.…”
mentioning
confidence: 99%
“…The quality assurance must cover all aspects of transfusion, including donor selection, blood collection, processing, storage, and transfusion. [1][2][3][4] The key role of quality in the transfusion system is well reflected in the standards of the American Association of Blood Banks (AABB) 5 and the Italian Society of Transfusion Medicine and Immunohematology (SIMTI). 6 On the contrary, the adoption of a quality assurance program is mandatory and regulated by the current Good Manufacturing Practice (cGMP) of the Food and Drug Administration (FDA) in the United States 7 and, in Europe, by the Directives 2002/98/EC and 2005/62/EC of the European Parliament, which must be adopted by all member states.…”
mentioning
confidence: 99%